These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experience. Cacchione A; Lodi M; Carai A; Miele E; Tartaglia M; Megaro G; Del Baldo G; Alessi I; Colafati GS; Carboni A; Boccuto L; Diomedi Camassei F; Catanzaro G; Po A; Ferretti E; Pedace L; Pizzi S; Folgiero V; Pezzullo M; Corsetti T; Secco DE; Cefalo MG; Locatelli F; Mastronuzzi A Int J Cancer; 2021 May; 148(10):2522-2534. PubMed ID: 33320972 [TBL] [Abstract][Full Text] [Related]
47. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250 [TBL] [Abstract][Full Text] [Related]
48. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study. Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438 [TBL] [Abstract][Full Text] [Related]
49. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
50. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites. Solano-Páez P; Fonseca A; Baroni LV; Amayiri N; Somarriba MP; Freytes C; Quiroga E; Rivero M; Márquez J; Lassaletta Á; Bouffet E J Neurooncol; 2022 Mar; 157(1):147-156. PubMed ID: 35122583 [TBL] [Abstract][Full Text] [Related]
51. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen? Lassman AB CNS Oncol; 2015; 4(5):341-6. PubMed ID: 26544062 [TBL] [Abstract][Full Text] [Related]
52. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre. Keogh RJ; Aslam R; Hennessy MA; Coyne Z; Hennessy BT; Breathnach OS; Grogan L; Morris PG BMC Cancer; 2021 Feb; 21(1):140. PubMed ID: 33557783 [TBL] [Abstract][Full Text] [Related]
53. Anti-angiogenic therapy for high-grade glioma. Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778 [TBL] [Abstract][Full Text] [Related]
54. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial. Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981 [TBL] [Abstract][Full Text] [Related]
55. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Bandopadhayay P; Bergthold G; London WB; Goumnerova LC; Morales La Madrid A; Marcus KJ; Guo D; Ullrich NJ; Robison NJ; Chi SN; Beroukhim R; Kieran MW; Manley PE Pediatr Blood Cancer; 2014 Jul; 61(7):1173-9. PubMed ID: 24482038 [TBL] [Abstract][Full Text] [Related]
56. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas. Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885 [TBL] [Abstract][Full Text] [Related]